ACM
TECH icon

Atlanta Capital Management’s Bio-Techne TECH Stock Holding History

Atlanta Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$134M Sell
1,889,964
-940
-0% -$81.2K 0.6% 62
2022
Q2 		$164M Sell
1,890,904
-59,216
-3% -$5.55M 0.71% 57
2022
Q1 		$211M Buy
1,950,120
+14,244
+0.7% +$1.47M 0.78% 51
2021
Q4 		$250M Sell
1,935,876
-31,760
-2% -$3.89M 0.85% 47
2021
Q3 		$238M Sell
1,967,636
-315,084
-14% -$38.3M 0.85% 45
2021
Q2 		$257M Sell
2,282,720
-212,260
-9% -$22.3M 0.89% 44
2021
Q1 		$238M Sell
2,494,980
-1,008,000
-29% -$92M 0.84% 49
2020
Q4 		$278M Sell
3,502,980
-12,200
-0.3% -$884K 1% 36
2020
Q3 		$218M Sell
3,515,180
-308,172
-8% -$20M 0.9% 47
2020
Q2 		$252M Sell
3,823,352
-1,627,544
-30% -$97.5M 1.07% 34
2020
Q1 		$258M Buy
5,450,896
+49,300
+0.9% +$2.47M 1.35% 19
2019
Q4 		$296M Sell
5,401,596
-17,688
-0.3% -$928K 1.23% 26
2019
Q3 		$265M Buy
5,419,284
+13,936
+0.3% +$699K 1.15% 25
2019
Q2 		$282M Buy
5,405,348
+43,920
+0.8% +$2.21M 1.26% 21
2019
Q1 		$266M Sell
5,361,428
-34,608
-0.6% -$1.56M 1.27% 23
2018
Q4 		$195M Sell
5,396,036
-1,013,956
-16% -$42.4M 1.08% 33
2018
Q3 		$327M Sell
6,409,992
-1,206,324
-16% -$53.4M 1.52% 23
2018
Q2 		$282M Sell
7,616,316
-59,908
-0.8% -$2.29M 1.42% 27
2018
Q1 		$290M Sell
7,676,224
-86,292
-1% -$3.05M 1.5% 23
2017
Q4 		$251M Sell
7,762,516
-22,168
-0.3% -$704K 1.32% 29
2017
Q3 		$235M Sell
7,784,684
-58,896
-0.8% -$1.75M 1.33% 29
2017
Q2 		$230M Buy
7,843,580
+57,164
+0.7% +$1.56M 1.35% 26
2017
Q1 		$198M Buy
7,786,416
+2,876,032
+59% +$74.2M 1.22% 29
2016
Q4 		$126M Buy
4,910,384
+12,340
+0.3% +$324K 0.8% 47
2016
Q3 		$134M Sell
4,898,044
-77,764
-2% -$2.14M 0.89% 40
2016
Q2 		$140M Sell
4,975,808
-20,984
-0.4% -$539K 0.94% 38
2016
Q1 		$118M Sell
4,996,792
-6,024
-0.1% -$133K 0.84% 41
2015
Q4 		$113M Buy
5,002,816
+484,876
+11% +$11.1M 0.82% 42
2015
Q3 		$104M Buy
4,517,940
+3,198,968
+243% +$80.2M 0.78% 44
2015
Q2 		$32.5M Sell
1,318,972
-16,580
-1% -$414K 0.22% 115
2015
Q1 		$33.5M Sell
1,335,552
-19,464
-1% -$463K 0.23% 119
2014
Q4 		$31.3M Buy
1,355,016
+197,804
+17% +$4.53M 0.22% 118
2014
Q3 		$27.1M Sell
1,157,212
-20,132
-2% -$472K 0.19% 120
2014
Q2 		$27.2M Sell
1,177,344
-40,044
-3% -$885K 0.19% 121
2014
Q1 		$26M Sell
1,217,388
-3,060
-0.3% -$68.9K 0.18% 128
2013
Q4 		$28.9M Sell
1,220,448
-8,236
-0.7% -$178K 0.19% 130
2013
Q3 		$24.6M Buy
1,228,684
+40,284
+3% +$764K 0.17% 129
2013
Q2 		$20.5M Buy
+1,188,400
New +$19.7M 0.16% 133

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Atlanta Capital Management's TECH Position: Q3 2022 in Review

Atlanta Capital Management reduced its Bio-Techne (TECH) stake by 0.05% in Q3 2022, selling an estimated $81.2K and leaving 1,889,964 shares worth $134M. The position accounts for 0.6% of the portfolio, ranked #62.

Atlanta Capital Management first reported a position in TECH in Q2 2013 and has held it in 38 quarters since. The position peaked at $327M in Q3 2018. 536 funds tracked by Wall St. Rank hold TECH as of Q3 2022.

  • Atlanta Capital Management held 1,889,964 shares of Bio-Techne worth $134M as of Q3 2022.
  • Atlanta Capital Management sold 940 Bio-Techne shares in Q3 2022, an estimated $81.2K.
  • Bio-Techne made up 0.6% of Atlanta Capital Management's portfolio in Q3 2022, its #62 holding.
  • Atlanta Capital Management first reported a position in Bio-Techne in Q2 2013 and has held it in 38 quarters since.
  • Atlanta Capital Management's Bio-Techne position peaked at $327M in Q3 2018.
  • 536 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2022.

Based on Atlanta Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.